China’s Public Payer Challenged To Support Domestic Innovative Drug Market

But Deficit Too Big?

 
• By Dexter Jie Yan
China domestic market
Can China’s public payer prop up the domestic novel drug market? • Source: Shutterstock

More from China

More from Focus On Asia